Emerade 150, 300 and 500 microgram adrenaline auto-injector devices. Further update 29th November

Emerade 150, 300 and 500 microgram adrenaline auto-injector devices. Further update 29th November

November 29, 2019

Further to the alert yesterday of a pharmacy level recall on Emerade all strengths, all Emerade devices will now be unavailable for the foreseeable future.

A management plan has been developed in collaboration with NHS England and NHS Improvement (NHSE&I), the British Society for Allergy & Clinical Immunology (BSACI), the MHRA and National patient groups. Full details can be found in the latest alert here.

 

 



Posted in:


More Latest News >